## Abstract A novel matrix metalloproteinase inhibitor, ABT‐518, [__S__‐(__R__^\*^, __R__^\*^)]‐__N__‐[1‐(2, 2‐dimethyl‐1,3‐dioxol‐4‐yl)‐2‐[[4‐[4‐(trifluoromethoxy)‐phenoxy]phenyl]sulfonyl]ethyl]‐__N__‐hydroxyformamide, was labeled with tritium in two phenyl rings in a seven‐step synthesis. The ove
Synthesis of [14C]ABT-770, matrix metalloproteinase inhibitor (MMPI), labelled in the phenoxy ring
✍ Scribed by Shirish N. Raja
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- French
- Weight
- 120 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0022-2135
- DOI
- 10.1002/jlcr.727
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The MMPI [^14^C]ABT‐770 (1), N‐[(1S)‐1‐[(4,4‐Dimethyl‐2,5‐dioxo‐1‐imi‐dazolidinyl)methyl]]‐2‐[[4′‐(trifluoromethoxy)[1,1′‐biphenyl]‐4‐yl]oxy]ethyl]‐N‐hydroxyformamide was synthesized in 8 steps using 4‐bromophenol‐UL‐^14^C (10) as a starting material. The Carbon‐14 label was introduced in one of the metabolically stable biphenyl rings. The key sequence of the synthesis was a three‐step one‐pot reaction in which the hydantoin moiety was introduced, the imine oxidized and further hydrolyzed to get the penultimate precursor to [^14^C]ABT‐770 (1) in 56% yield. Copyright © 2003 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract 1‐Nitro‐9/dimethylaminopropylamino/‐acridine dihydro‐chloride /C‐283, ‘Ledaarin’/ is used as an anti‐twnor drug, In view of the studies on its mechanism of action. the syntheses of two specimens of this compound labelled with radioisotopes have been carried out. One of them contained C^